Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in PDSB — PDS Biotechnology Corp

CIK 1000275 TORONTO, A6
Back to PDSB Full portfolio

Position in PDSB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$70
+$25 QoQ
Shares Held
80
+6.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 52 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PDSB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. PDSB ranks #400 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in PDSB

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $70 80
2026-03-31 $45 75
2025-12-31 $50 65
2025-09-30 $1,881 1,863
2025-06-30 $9,501 7,144
2025-03-31 $342 288
2024-12-31 $2,428 1,490
2024-09-30 $9,901 2,592
2024-06-30 $34,010 11,608
2024-03-31 $11,804 2,981
2023-12-31 $55,339 11,135
2023-09-30 $29,466 5,835
2023-06-30 $9,979 1,984
2023-03-31 $1,537 250
2022-12-31 $3,300 250
2022-09-30 $747 252
2022-06-30 $912 250
2022-03-31 $8,801 1,422
2021-12-31 $4,090 505
2021-03-31 $18,200 4,000